CATCHWORDS
INTELLECTUAL PROPERTY - patent application - appeal from decision of delegate of Commissioner of Patents - whether Court has power to direct patent application to proceed to grant subject to amendments directed by Court.
Patents Act 1990 (Cth) ss 60, 104, 107, 160
Federal Court Rules: O 29
Kaiser Aluminium & Chemical Corporation v The Reynolds Metal Co (1969) 120 CLR 136
Genetics Institute Inc v Kirin-Amgen Inc
(No. VG 868 of 1995)
Judge: Heerey J
Date: 4 July 1996
Place: Melbourne (heard in Canberra)
IN THE FEDERAL COURT OF AUSTRALIA )
)
VICTORIA DISTRICT REGISTRY ) No.VG 868 of 1995
)
GENERAL DIVISION )
B E T W E N:
GENETICS INSTITUTE INC.
Applicant
- and -
KIRIN-AMGEN INC.
Respondent
JUDGE: Heerey J
DATE: 4 July 1996
PLACE: Melbourne (heard in Canberra)
MINUTES OF ORDER
The Court orders that:
Answer the question:
Whether, if the Court is of the view that any of the claims are bad but can be cured by amendment, the Court has the power to direct that the patent application proceed to grant, together with any amendment?
Yes.
Order that the applicant pay the respondent's costs of the hearing on 21 June 1996 but that otherwise the costs of the notice of motion dated 31 May 1996 be reserved.
NOTE: Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules
IN THE FEDERAL COURT OF AUSTRALIA )
)
VICTORIA DISTRICT REGISTRY ) No.VG 868 of 1995
)
GENERAL DIVISION )
B E T W E N:
GENETICS INSTITUTE INC.
Applicant
- and -
KIRIN-AMGEN INC.
Respondent
JUDGE: Heerey J
DATE: 4 July 1996
PLACE: Melbourne (heard in Canberra)
REASONS FOR JUDGMENT
The applicant Genetics Institute Inc (Genetics) has appealed to this Court under s 60(4) of the Patents Act 1990 (Cth) (the Act) against the decision of a delegate of the Commissioner of Patents given on 19 October 1995 to grant a patent for a pharmaceutical product to the respondent Kirin-Amgen Inc (Kirin-Amgen). The delegate decided that Genetics' opposition to the grant of a patent on Kirin-Amgen's application failed so far as most of the claims were concerned. He decided that the opposition to the remaining claims succeeded but only on grounds that, in respect of some, they did not comply with s 40 and involved "some minor lack of clarity", and that, in respect of the others, they were not fairly based. In respect of the claims on which the opposition succeeded the delegate held that the defects could be "readily overcome" and allowed Kirin-Amgen 60 days "to propose appropriate amendments".
Kirin-Amgen has cross-appealed against the delegate's decision insofar as it upheld objections to claims and seeks a declaration that each of such claims is valid.
Following an order made on 3 June 1996, on the application of Kirin-Amgen, I now…
Keep reading for free
Create a free CaseChat account to read Genetics Institute Inc v Kirin-Amgen Inc and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [1996] FCA 540
- Decision Date
CaseChat Overview and Summary
The Court examined the relevant provisions of the Patents Act and the Federal Court Rules to determine its jurisdiction. Section 160 of the Act provides that the Federal Court may make any order it thinks fit in all the circumstances when hearing an appeal against a decision of the Commissioner. The Court considered the broad language of section 160(e) and the historical context of appellate jurisdiction, which typically allows for variation of the decision under appeal. The Court found that the power to order amendments was implicit in the grant of jurisdiction to vary the Commissioner's decision. The Court also noted that the Commissioner himself has the power to direct amendments, which supports the view that the Court can similarly order amendments as part of its jurisdiction over patent applications. The Court concluded that it does indeed have the power to direct that the patent application proceed to grant subject to amendments, if it finds that the claims can be cured by amendment.
The Court's reasoning was based on the broad and flexible language of the statute, the historical understanding of appellate jurisdiction, and the specific powers granted to the Commissioner. The Court rejected the argument that its jurisdiction was limited to deciding whether the patent should proceed to grant without considering amendments, finding that such an interpretation would be unduly restrictive and inconsistent with the powers conferred on the Commissioner. The Court found that the power to order amendments is a necessary part of its jurisdiction to review the Commissioner's decisions and ensure that patents are granted in accordance with the law.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.